Business● Low1h ago · Nov 5, 2026, 5:30 AM
NewAmsterdam Pharma GAAP EPS of -$0.14 beats by $0.30, revenue of $19.16M beats by $4.11M
GlobeAlert Desk · curated from Seeking Alpha Tech · global
NewAmsterdam Pharma reported GAAP EPS of -$0.14, beating estimates by $0.30, and revenue of $19.16M, exceeding expectations by $4.11M. This indicates the company's financial performance surpassed analyst forecasts.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business10m agoFinTribe brings women, financial experts together to promote wealth creationVanguard NigeriaBusiness11m agoToyota Motor posts GAAP EPS of ¥185.97 and ¥26.96T revenue; raises full-year FY2027 forecastSeeking Alpha TechBusiness13m agoUS asset manager Federated Hermes opens Hong Kong office to tap China’s tech riseSouth China Morning PostBusiness16m agoNintendo Switch 2 sales plunge 41% as price hikes and memory crunch biteCNBC